Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 282

1.

Maternal immunization with RSV fusion glycoprotein vaccine and substantial protection of neonatal baboons against respiratory syncytial virus pulmonary challenge.

Welliver RC, Papin JF, Preno A, Ivanov V, Tian JH, Lu H, Guebre-Xabier M, Flyer D, Massare MJ, Glenn G, Ellingsworth L, Smith G.

Vaccine. 2019 Nov 21. pii: S0264-410X(19)31510-5. doi: 10.1016/j.vaccine.2019.11.003. [Epub ahead of print]

PMID:
31761502
2.

Comparison of manual and automated fiber quantification tractography in patients with temporal lobe epilepsy.

Kreilkamp BAK, Lisanti L, Glenn GR, Wieshmann UC, Das K, Marson AG, Keller SS.

Neuroimage Clin. 2019;24:102024. doi: 10.1016/j.nicl.2019.102024. Epub 2019 Oct 17.

3.

Vaccine innovations for emerging infectious diseases-a symposium report.

Cable J, Srikantiah P, Crowe JE Jr, Pulendran B, Hill A, Ginsberg A, Koff W, Mathew A, Ng T, Jansen K, Glenn G, Permar S, Wilson I, Weiner DB, Weissman D, Rappuoli R.

Ann N Y Acad Sci. 2019 Oct 28. doi: 10.1111/nyas.14235. [Epub ahead of print]

PMID:
31659752
4.

A Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein (EBOV GP) Nanoparticle Vaccine with Matrix-M™ Adjuvant in Healthy Adults.

Fries L, Cho I, Krähling V, Fehling SK, Strecker T, Becker S, Hooper JW, Kwilas SA, Agrawal S, Wen J, Lewis M, Fix A, Thomas N, Flyer D, Smith G, Glenn G.

J Infect Dis. 2019 Oct 11. pii: jiz518. doi: 10.1093/infdis/jiz518. [Epub ahead of print]

PMID:
31603201
5.

Evaluation of transcutaneous immunization as a delivery route for an enterotoxigenic E. coli adhesin-based vaccine with CfaE, the colonization factor antigen 1 (CFA/I) tip adhesin.

Rollenhagen JE, Woods CM, O'Dowd A, Poole ST, Tian JH, Guebre-Xabier M, Ellingsworth L, Prouty MG, Glenn G, Savarino SJ.

Vaccine. 2019 Sep 30;37(42):6134-6138. doi: 10.1016/j.vaccine.2019.08.057. Epub 2019 Sep 3.

6.

Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.

Patel N, Massare MJ, Tian JH, Guebre-Xabier M, Lu H, Zhou H, Maynard E, Scott D, Ellingsworth L, Glenn G, Smith G.

Vaccine. 2019 Sep 24;37(41):6112-6124. doi: 10.1016/j.vaccine.2019.07.089. Epub 2019 Aug 12.

7.

Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.

Muňoz FM, Swamy GK, Hickman SP, Agrawal S, Piedra PA, Glenn GM, Patel N, August AM, Cho I, Fries L.

J Infect Dis. 2019 Oct 22;220(11):1802-1815. doi: 10.1093/infdis/jiz390.

PMID:
31402384
8.

Optimization of data acquisition and analysis for fiber ball imaging.

Moss HG, McKinnon ET, Glenn GR, Helpern JA, Jensen JH.

Neuroimage. 2019 Oct 15;200:690-703. doi: 10.1016/j.neuroimage.2019.07.005. Epub 2019 Jul 5.

PMID:
31284026
9.

Ketalization of 2-heptanone to prolong its activity as mite repellant for the protection of honey bees.

Borries FA, Kudla AM, Kim S, Allston TD, Eddingsaas NC, Shey J, Orts WJ, Klamczynski AP, Glenn GM, Miri MJ.

J Sci Food Agric. 2019 Nov;99(14):6267-6277. doi: 10.1002/jsfa.9900. Epub 2019 Aug 12.

PMID:
31259414
10.

Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein.

Xie Q, Wang Z, Ni F, Chen X, Ma J, Patel N, Lu H, Liu Y, Tian JH, Flyer D, Massare MJ, Ellingsworth L, Glenn G, Smith G, Wang Q.

PLoS One. 2019 Feb 7;14(2):e0210749. doi: 10.1371/journal.pone.0210749. eCollection 2019.

11.

Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.

Gilbert BE, Patel N, Lu H, Liu Y, Guebre-Xabier M, Piedra PA, Glenn G, Ellingsworth L, Smith G.

Vaccine. 2018 Dec 18;36(52):8069-8078. doi: 10.1016/j.vaccine.2018.10.073. Epub 2018 Oct 30.

PMID:
30389195
12.

Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge.

Liu Y, Ye L, Lin F, Gomaa Y, Flyer D, Carrion R Jr, Patterson JL, Prausnitz MR, Smith G, Glenn G, Wu H, Compans RW, Yang C.

Sci Rep. 2018 Jul 25;8(1):11193. doi: 10.1038/s41598-018-29135-w.

13.

Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate.

Luke T, Bennett RS, Gerhardt DM, Burdette T, Postnikova E, Mazur S, Honko AN, Oberlander N, Byrum R, Ragland D, St Claire M, Janosko KB, Smith G, Glenn G, Hooper J, Dye J, Pal S, Bishop-Lilly KA, Hamilton T, Frey K, Bollinger L, Wada J, Wu H, Jiao JA, Olinger GG, Gunn B, Alter G, Khurana S, Hensley LE, Sullivan E, Jahrling PB.

J Infect Dis. 2018 Nov 22;218(suppl_5):S636-S648. doi: 10.1093/infdis/jiy377.

14.

Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine.

Shinde V, Fries L, Wu Y, Agrawal S, Cho I, Thomas DN, Spindler M, Lindner E, Hahn T, Plested J, Flyer D, Massare MJ, Zhou B, Fix A, Smith G, Glenn GM.

N Engl J Med. 2018 Jun 14;378(24):2346-2348. doi: 10.1056/NEJMc1803554. No abstract available.

15.

Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge.

Liu Y, Ye L, Lin F, Gomaa Y, Flyer D, Carrion R Jr, Patterson JL, Prausnitz MR, Smith G, Glenn G, Wu H, Compans RW, Yang C.

J Infect Dis. 2018 Nov 22;218(suppl_5):S545-S552. doi: 10.1093/infdis/jiy267.

16.

The Vari-Simplex Discipline.

Glenn G.

J Clin Orthod. 2017 Sep;51(9):532-535. No abstract available.

PMID:
29130909
17.

Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.

Smith G, Liu Y, Flyer D, Massare MJ, Zhou B, Patel N, Ellingsworth L, Lewis M, Cummings JF, Glenn G.

Vaccine. 2017 Sep 25;35(40):5366-5372. doi: 10.1016/j.vaccine.2017.08.021. Epub 2017 Aug 22.

18.

Solution blow spun nanocomposites of poly(lactic acid)/cellulose nanocrystals from Eucalyptus kraft pulp.

Parize DDDS, Oliveira JE, Williams T, Wood D, Avena-Bustillos RJ, Klamczynski AP, Glenn GM, Marconcini JM, Mattoso LHC.

Carbohydr Polym. 2017 Oct 15;174:923-932. doi: 10.1016/j.carbpol.2017.07.019. Epub 2017 Jul 10.

PMID:
28821149
19.

Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.

Tian JH, Glenn G, Flyer D, Zhou B, Liu Y, Sullivan E, Wu H, Cummings JF, Elllingsworth L, Smith G.

Vaccine. 2017 Jul 24;35(33):4079-4087. doi: 10.1016/j.vaccine.2017.06.062. Epub 2017 Jun 29.

20.

Structural plasticity of the ventral stream and aphasia recovery.

McKinnon ET, Fridriksson J, Glenn GR, Jensen JH, Helpern JA, Basilakos A, Rorden C, Shih AY, Spampinato MV, Bonilha L.

Ann Neurol. 2017 Jul;82(1):147-151. doi: 10.1002/ana.24983.

21.

Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.

Smith GE, Sun X, Bai Y, Liu YV, Massare MJ, Pearce MB, Belser JA, Maines TR, Creager HM, Glenn GM, Flyer D, Pushko P, Levine MZ, Tumpey TM.

Virology. 2017 Sep;509:90-97. doi: 10.1016/j.virol.2017.06.006. Epub 2017 Jun 16.

22.

A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.

August A, Glenn GM, Kpamegan E, Hickman SP, Jani D, Lu H, Thomas DN, Wen J, Piedra PA, Fries LF.

Vaccine. 2017 Jun 27;35(30):3749-3759. doi: 10.1016/j.vaccine.2017.05.045. Epub 2017 Jun 1.

23.

Solution Blow Spinning of Food-Grade Gelatin Nanofibers.

Liu F, Avena-Bustillos RJ, Bilbao-Sainz C, Woods R, Chiou BS, Wood D, Williams T, Yokoyama W, Glenn GM, McHugh TH, Zhong F.

J Food Sci. 2017 Jun;82(6):1402-1411. doi: 10.1111/1750-3841.13710. Epub 2017 May 4.

PMID:
28471491
24.

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults.

Fries L, Shinde V, Stoddard JJ, Thomas DN, Kpamegan E, Lu H, Smith G, Hickman SP, Piedra P, Glenn GM.

Immun Ageing. 2017 Apr 12;14:8. doi: 10.1186/s12979-017-0090-7. eCollection 2017.

25.

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.

Coleman CM, Venkataraman T, Liu YV, Glenn GM, Smith GE, Flyer DC, Frieman MB.

Vaccine. 2017 Mar 14;35(12):1586-1589. doi: 10.1016/j.vaccine.2017.02.012. Epub 2017 Feb 23.

26.

Evaluating kurtosis-based diffusion MRI tissue models for white matter with fiber ball imaging.

Jensen JH, McKinnon ET, Glenn GR, Helpern JA.

NMR Biomed. 2017 May;30(5). doi: 10.1002/nbm.3689. Epub 2017 Jan 13.

27.

Preoperative automated fibre quantification predicts postoperative seizure outcome in temporal lobe epilepsy.

Keller SS, Glenn GR, Weber B, Kreilkamp BA, Jensen JH, Helpern JA, Wagner J, Barker GJ, Richardson MP, Bonilha L.

Brain. 2017 Jan;140(1):68-82. doi: 10.1093/brain/aww280. Epub 2016 Nov 15.

28.

Dependence on b-value of the direction-averaged diffusion-weighted imaging signal in brain.

McKinnon ET, Jensen JH, Glenn GR, Helpern JA.

Magn Reson Imaging. 2017 Feb;36:121-127. doi: 10.1016/j.mri.2016.10.026. Epub 2016 Oct 27.

29.

Preparation of Zein Fibers Using Solution Blow Spinning Method.

Liu F, Avena-Bustillos RJ, Woods R, Chiou BS, Williams TG, Wood DF, Bilbao-Sainz C, Yokoyama W, Glenn GM, McHugh TH, Zhong F.

J Food Sci. 2016 Dec;81(12):N3015-N3025. doi: 10.1111/1750-3841.13537. Epub 2016 Nov 9.

PMID:
27861896
30.

Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle.

Dye JM, Wu H, Hooper JW, Khurana S, Kuehne AI, Coyle EM, Ortiz RA, Fuentes S, Herbert AS, Golding H, Bakken RA, Brannan JM, Kwilas SA, Sullivan EJ, Luke TC, Smith G, Glenn G, Li W, Ye L, Yang C, Compans RW, Tripp RA, Jiao JA.

Sci Rep. 2016 Apr 25;6:24897. doi: 10.1038/srep24897.

31.

Epilepsy-related cytoarchitectonic abnormalities along white matter pathways.

Glenn GR, Jensen JH, Helpern JA, Spampinato MV, Kuzniecky R, Keller SS, Bonilha L.

J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):930-6. doi: 10.1136/jnnp-2015-312980. Epub 2016 Apr 13.

PMID:
27076491
32.

Mapping the Orientation of White Matter Fiber Bundles: A Comparative Study of Diffusion Tensor Imaging, Diffusional Kurtosis Imaging, and Diffusion Spectrum Imaging.

Glenn GR, Kuo LW, Chao YP, Lee CY, Helpern JA, Jensen JH.

AJNR Am J Neuroradiol. 2016 Jul;37(7):1216-22. doi: 10.3174/ajnr.A4714. Epub 2016 Mar 3.

33.

Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.

Bengtsson KL, Song H, Stertman L, Liu Y, Flyer DC, Massare MJ, Xu RH, Zhou B, Lu H, Kwilas SA, Hahn TJ, Kpamegan E, Hooper J, Carrion R Jr, Glenn G, Smith G.

Vaccine. 2016 Apr 7;34(16):1927-35. doi: 10.1016/j.vaccine.2016.02.033. Epub 2016 Feb 24.

34.

Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.

Luke T, Wu H, Zhao J, Channappanavar R, Coleman CM, Jiao JA, Matsushita H, Liu Y, Postnikova EN, Ork BL, Glenn G, Flyer D, Defang G, Raviprakash K, Kochel T, Wang J, Nie W, Smith G, Hensley LE, Olinger GG, Kuhn JH, Holbrook MR, Johnson RF, Perlman S, Sullivan E, Frieman MB.

Sci Transl Med. 2016 Feb 17;8(326):326ra21. doi: 10.1126/scitranslmed.aaf1061.

PMID:
26888429
35.

Controlled Release of Linalool Using Nanofibrous Membranes of Poly(lactic acid) Obtained by Electrospinning and Solution Blow Spinning: A Comparative Study.

Souza MA, Oliveira JE, Medeiros ES, Glenn GM, Mattoso LH.

J Nanosci Nanotechnol. 2015 Aug;15(8):5628-36.

PMID:
26369129
36.

Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs.

Glenn GM, Fries LF, Smith G, Kpamegan E, Lu H, Guebre-Xabier M, Hickman SP, Flyer D.

Vaccine. 2015 Nov 25;33(47):6488-92. doi: 10.1016/j.vaccine.2015.08.039. Epub 2015 Aug 28.

37.

Optimization of white matter fiber tractography with diffusional kurtosis imaging.

Glenn GR, Helpern JA, Tabesh A, Jensen JH.

NMR Biomed. 2015 Oct;28(10):1245-56. doi: 10.1002/nbm.3374. Epub 2015 Aug 14.

PMID:
26275886
38.

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.

Glenn GM, Fries LF, Thomas DN, Smith G, Kpamegan E, Lu H, Flyer D, Jani D, Hickman SP, Piedra PA.

J Infect Dis. 2016 Feb 1;213(3):411-22. doi: 10.1093/infdis/jiv406. Epub 2015 Aug 10.

PMID:
26259809
39.

ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans.

Chung KY, Coyle EM, Jani D, King LR, Bhardwaj R, Fries L, Smith G, Glenn G, Golding H, Khurana S.

Vaccine. 2015 Jul 31;33(32):3953-62. doi: 10.1016/j.vaccine.2015.06.047. Epub 2015 Jun 17.

PMID:
26093202
40.

CT Evaluation of Small-Diameter Coronary Artery Stents: Effect of an Integrated Circuit Detector with Iterative Reconstruction.

Geyer LL, Glenn GR, De Cecco CN, Van Horn M, Canstein C, Silverman JR, Krazinski AW, Kemper JM, Bucher A, Ebersberger U, Costello P, Bamberg F, Schoepf UJ.

Radiology. 2015 Sep;276(3):706-14. doi: 10.1148/radiol.15140427. Epub 2015 Mar 17.

PMID:
25786157
41.

Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.

Liu YV, Massare MJ, Pearce MB, Sun X, Belser JA, Maines TR, Creager HM, Glenn GM, Pushko P, Smith GE, Tumpey TM.

Vaccine. 2015 Apr 27;33(18):2152-8. doi: 10.1016/j.vaccine.2015.03.009. Epub 2015 Mar 13.

42.

Caregiver tele-support group for Parkinson's disease: A pilot study.

Shah SP, Glenn GL, Hummel EM, Hamilton JM, Martine RR, Duda JE, Wilkinson JR.

Geriatr Nurs. 2015 May-Jun;36(3):207-11. doi: 10.1016/j.gerinurse.2015.02.002. Epub 2015 Mar 3.

PMID:
25744558
43.

Quantitative assessment of diffusional kurtosis anisotropy.

Glenn GR, Helpern JA, Tabesh A, Jensen JH.

NMR Biomed. 2015 Apr;28(4):448-59. doi: 10.1002/nbm.3271. Epub 2015 Feb 26.

44.

In vitro antimicrobial activity of solution blow spun poly(lactic acid)/polyvinylpyrrolidone nanofibers loaded with Copaiba (Copaifera sp.) oil.

Bonan RF, Bonan PR, Batista AU, Sampaio FC, Albuquerque AJ, Moraes MC, Mattoso LH, Glenn GM, Medeiros ES, Oliveira JE.

Mater Sci Eng C Mater Biol Appl. 2015 Mar;48:372-7. doi: 10.1016/j.msec.2014.12.021. Epub 2014 Dec 9.

PMID:
25579936
45.

Torrefaction of pomaces and nut shells.

Chiou BS, Valenzuela-Medina D, Bilbao-Sainz C, Klamczynski AK, Avena-Bustillos RJ, Milczarek RR, Du WX, Glenn GM, Orts WJ.

Bioresour Technol. 2015 Feb;177:58-65. doi: 10.1016/j.biortech.2014.11.071. Epub 2014 Nov 20.

PMID:
25479394
46.

Maternal immunization: opportunities for scientific advancement.

Beigi RH, Fortner KB, Munoz FM, Roberts J, Gordon JL, Han HH, Glenn G, Dormitzer PR, Gu XX, Read JS, Edwards K, Patel SM, Swamy GK.

Clin Infect Dis. 2014 Dec 15;59 Suppl 7:S408-14. doi: 10.1093/cid/ciu708.

47.

An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization.

Raghunandan R, Lu H, Zhou B, Xabier MG, Massare MJ, Flyer DC, Fries LF, Smith GE, Glenn GM.

Vaccine. 2014 Nov 12;32(48):6485-92. doi: 10.1016/j.vaccine.2014.09.030. Epub 2014 Sep 28.

48.

A simple noise correction scheme for diffusional kurtosis imaging.

Glenn GR, Tabesh A, Jensen JH.

Magn Reson Imaging. 2015 Jan;33(1):124-33. doi: 10.1016/j.mri.2014.08.028. Epub 2014 Aug 28.

49.

Orthodontists encourage use of mouth guards for all contact sports.

Glenn G.

N J Nurse. 2014 Jul;44(3):8. No abstract available.

PMID:
25007504
50.

Identification and mutagenesis of the TACE and γ-secretase cleavage sites in the colony-stimulating factor 1 receptor.

Vahidi A, Glenn G, van der Geer P.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):782-7. doi: 10.1016/j.bbrc.2014.06.061. Epub 2014 Jun 21.

PMID:
24955855

Supplemental Content

Support Center